Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Pfizer Inc (NYSE:PFE)

33.87
Delayed Data
As of Sep 30
 +0.55 / +1.65%
Today’s Change
28.25
Today|||52-Week Range
37.39
+4.93%
Year-to-Date
Vanguard Windsor II: Vanguards Oddball
12:43pm / MotleyFool.com - Paid Partner Content
England's chief medic says NHS should fund drug to prevent HIV
Sep 30 / FT.com - Paid Partner Content
Why Pfizer's Scrapped Merger May Ultimately Benefit the Company and Investors
8:27am / TheStreet.com - Paid Partner Content
Deutsche Bank's Losses Affecting the Market on Thursday
Sep 29 / GuruFocus News - Paid Partner Content
US Market Indexes Gain on Friday
Sep 30 / GuruFocus News - Paid Partner Content
Why Exelixis, Inc. Continued Its Downfall Today
Sep 29 / MotleyFool.com - Paid Partner Content
3 Top Healthcare Stocks to Buy Now
Sep 30 / MotleyFool.com - Paid Partner Content
Troubles for Deutsche Bank, Wells Fargo Drag Down Wall Street
Sep 29 / TheStreet.com - Paid Partner Content
ARIAD (ARIA) Leukemia Drug Iclusig Gets Approval in Japan
Sep 30 / Zacks.com - Paid Partner Content
The Highest-Yielding Drug Stocks
Sep 29 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close33.32
Today’s open33.44
Day’s range33.40 - 34.02
Volume27,815,892
Average volume (3 months)21,224,682
Market cap$205.4B
Dividend yield3.54%
Data as of 4:00pm ET, 09/30/2016

Growth & Valuation

Earnings growth (last year)-21.24%
Earnings growth (this year)+11.73%
Earnings growth (next 5 years)+6.90%
Revenue growth (last year)-1.52%
P/E ratio30.0
Price/Sales4.13
Price/Book3.23

Competitors

 Today’s
change
Today’s
% change
NVSNovartis-0.29-0.37%
MRKMerck+0.50+0.81%
GSKGlaxoSmithKline+0.23+0.54%
ABBVAbbVie+0.25+0.40%
Data as of 4:02pm ET, 09/30/2016

Financials

Next reporting dateNovember 1, 2016
EPS forecast (this quarter)$0.62
Annual revenue (last year)$48.9B
Annual profit (last year)$7.0B
Net profit margin14.22%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chairman &
Chief Executive Officer
Ian C. Read
Chief Financial Officer &
EVP-Business Operations
Frank A. D'Amelio
Corporate headquarters
New York, New York

Forecasts

Search for Jobs